41
Views
3
CrossRef citations to date
0
Altmetric
Research Article

The pathology of oral cancer

, &
Pages 376-383 | Published online: 06 Jul 2009

References

  • Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80: 827–41.
  • Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 18–29.
  • Australian Institute of Health and Welfare (AIHW) and Australasian Association of Cancer Registries (AACR). Cancer in Australia, 1999. AIHW cat. no. CAN 15. Canberra: AIHW (Cancer Series No. 20). 2002.
  • Australian Institute of Health and Welfare (AIHW). Australasian Association of Cancer Registries (AACR). Canberra: National Cancer Statistics Clearing House (NCSCH). 1983-1996.
  • Parkin DM, Laara E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers. Int J Cancer 1988; 41: 184–97.
  • MacFarlane GJ, McCredie M, Coates M. Patterns of oral and pharyngeal cancer incidence in New South Wales, Australia. J Oral Path Med 1994; 23: 241–5.
  • MacFarlane GJ, Sharp L, Porter S, Franceschi S. Trends in survival from cancers of the oral cavity and pharynx in Scotland: a clue as to why the disease is becoming more common? Br J Cancer 1996; 73: 805–8.
  • NSW Central Cancer Registry Cancer Control Information Centre. Survival from Cancer in New South Wales: 1980–1995. Sydney: NSW Cancer Council. 1999.
  • Wynder EL, Bross U. Aetiological factors in mouth cancer. Br Med J 1957; i: 1137–43.
  • International Agency for Research on Cancer (IARC). Tobacco smoking. IARC Monograph on the evaluation of carcinogenic risks of chemicals to humans. Lyon, France: IARC, 1986; 38:1–421.
  • Scully C, Field JK, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 2000; 36: 256–63.
  • Park JY, Muscat JE, Ren Q, et al. CYPIAI and GSTMI polymorphisms and oral cancer risk. Cancer Epidemiol Biomarkers Prey 1997; 6: 791–7.
  • Kawajiri K, Fujii-Kuriyama Y. P450 and human cancer. Jpn J Cancer Res 1991; 82: 1325–35.
  • Coutelle C, Ward PJ, Fleury B, et al. Laryngeal and oropharyngeal cancer, alcohol dehydrogenase 3 and glutathione-S-transferase MI polymorphisms. Hum Genet 1997; 99: 319–25.
  • Gheng L, Eicher SA, Guo Z, Hong WK, Spitz MR, Wei Q. Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol Biomarkers Prey 1998; 7: 465–8.
  • Spitz MR, Fueger ii, Beddingheld NA, et al. Chromosome sensitivity to bleomycin induced mutagenesis an independent risk factor for upper aerodigestive tract cancer. Cancer Res. 1989; 49: 4262–8.
  • Brugere J, Guenel P, Leclerc A, Rodriquez J. Differential effects of tobacco and alcohol in cancer of the larynx, pharynx, and mouth. Cancer 1986; 57: 391–5.
  • Blot WJ. Alcohol and cancer. Cancer Res ( Suppl) 1992; 52: 21I9s–2123s.
  • International Agency for Research on Cancer (IARC). Alcohol Drinking. IARC Monograph on the evaluation of carcinogenic risks of chemicals to humans. Lyon, France: IARC, 1989; 44: 1–416.
  • Harty LC, Caporaso NE, Hayes RB, et al. Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancer. J Natl Cancer Inst 1997; 89: 1698–705.
  • Sinor PN, Gupta PC, Murti PR, et al. A case control study of oral submucous fibrosis with special reference to the etiologic role of areca nut. J Oral Pathol Med 1990; 19: 94–8.
  • Murti PR, Bhonsle RB, Pindborg ii, Daftary DK, Gupta PC, Mehta FS. Malignant transformation rate in oral submucous fibrosis over a 17 year period. Community Dent Oral Epidemiol 1985; 13: 340–1.
  • Daftary D, Murti P, Bhonsle R, Gupta P, Mehta F, Pindborg Risk Markers for Oral Diseases, Vol 2, Oral Cancer. Cambridge: Cambridge University Press. 1991; 29–62.
  • Henderson BE, Aiken GH. Cancer in Papua New Guinea. Monograph 53. Bethesda: National Cancer Institute. 1979; 67–72.
  • Nair UJ, Floyd RA, Nair J, Busachini V, Friesen M, Bartsch H. Formation of reactive oxygen species and of 8-0H-dG in DNA in vitro with betel quid ingredients. Chem Biol Interact 1987; 63: 157–69.
  • Nair UJ, Ohshima H, Frisen M, Croisy A, Bhide SV, Bartsch H. Tobacco specific and betel nut specific N-nitroso compounds: occurrence in saliva and urine of betel quid chewers and formation in vitro by nitrosation of betel quid. Carcinogenesis 1985; 6: 295–303.
  • Prokopczyk B, Rivenson A, Bertinato P, Brunneman K, Hoffmann D. 3-(Methylnitrosamino) propionitrile: occurrence in saliva of betel quid chewers, carcinogenicity and DNA methylation in F344 rats. Cancer Res 1987; 47: 467–71.
  • Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht S. Induction of lung and exocrinepancreas tumours in F344 rats by tobacco specific and areca derived N-nitrosamines. Cancer Res 1988; 48: 6912–7.
  • McLaughlin JK, Gridley G, Block G. Dietary factors in oral and pharyngeal cancer. J Natl Cancer Inst 1988; 80: 1237–43.
  • De Stefani E, Deneo-Pellegrini H, Mendilaharsu M, Ronco A. Diet and risk of cancer of the upper aerodigestive tract. I. Foods. Oral Oncol 1999; 35: 17–21.
  • De Stefani E, Ronco A, Mendilaharsu M, Deneo-Pellegrini H. Diet and risk of cancer of the upper aerodigestive tract. II. Nutrients. Oral Oncol 1999; 35: 22–6.
  • Scully C. Viruses and oral squamous carcinoma. Eur J Cancer B Oral Oncol 1992; 28B: 57–9.
  • Johnson FB. Chemical interaction with herpes simplex type 2 virus: enhancement of transformation by selected chemical carcinogens and procarcinogens. Carcinogenesis 1982; 3: 1235–40.
  • DiPaolo JA, Woodworth CD, Popescu NC, Koval DL, Lopez TV, Doniger J. HSV-2 induced tumorigenicity in HPV-16 immortalised human genital keratinocytes. Virology 1990; 177: 777–9.
  • Scully C. New aspects of oral viral diseases. Curr Top Pathol 1996; 90: 29–96.
  • Scully C. Oral squamous cell carcinoma; from a hypothesis about a virus, to concern about possible sexual transmission. Oral Oncol 2002; 38: 227–34.
  • Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709–20.
  • Cawson RA. Leukoplakia and oral cancer. Proc R Soc Med 1969; 62: 610–6.
  • Krogh P, Haid B, Holmstrup P. Possible mycological aetiology of oral mucosal cancer. Catalytic potential of infecting Candida albicans and other yeast production of N-nitrosobenzyl methylamine. Carcino-genesis 1987; 8: 1543–8.
  • Arendorf TM, Walker DM, Kingdom RJ, Roll JRS, Newcombe RG. Tobacco smoking and denture wearing in oral candidal leukoplakia. Br Dent J 1983; 155: 340–3.
  • Walker DM. Candidal infection of the oral mucosa. In: Dolby AE, editor. Oral Mucosa in Health and Disease. London: Blackwell, 1975: 467–505.
  • Meyer I, Shklar G. The oral manifestations of acquired syphilis. Oral Surg Oral Med Oral Pathol 1967; 23: 45–57.
  • Firth NA. Marijuana use and oral cancer: a review. Oral Oncol 1997; 33: 398–401.
  • Scully C, Laskaris G, Pindborg ii, Porter SR, Reichart P. Oral manifestations of HIV and their management. 1. More common lesions. Oral Surg Oral Med Oral Pathol 1991; 71: 158–66.
  • Flaitz CM, Hicks Mi. Role of lymphotrotrophic herpesvirus in malignancies associated with immunosuppressed states. In: Millard HD, Mason DK, editors. Perspectives on the 1998 3rd World Workshop on Oral Medicine. Ann Arbor, MI: University of Michigan Press, 2000.
  • Harris JP, Penn I. Immunosuppression and the development of malignancies of the upper airway and related structures. Laryngoscope 1981; 91: 520–8.
  • Foulkes WD, Brunet JS, Kowalski LP, Narod SA, Franco EL. Family history is a risk factor for squamous cell carcinoma of the head and neck in Brazil: a case-control study. Int J Cancer 1995; 63: 769–73.
  • Foulkes WD, Brunet JS, Sieh W, Black MJ, Shenouda G, Narod SA. Familial risk of squamous cell carcinoma of the head and neck: a retrospective case-control study. Br Med J 1996; 313: 716–20.
  • Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark and Finland. New Eng J Med 2000; 343: 78–85.
  • Pindborg ii, Reichart PA, Smith CJ, van der Waal I. World Health Organisation. International Histological Classification of Tumours: Histological Typing of Cancer and Precancer of the Oral Mucosa. 2nd ed. Berlin, Heidleberg: Springer, 1997; 1–40.
  • Mincer HH, Coleman SA, Hopkins KP. Observations on the clinical characteristics of oral lesions showing histologic epithelial dysplasia. Oral Surg 1972; 33: 389–99.
  • Sudbo J, Kildal W, Risberg B, Koppang HS, Danielsen HE. DNA content as a prognostic marker in patients with oral leukoplakia. New Eng J Med 2001; 344: 1270–8.
  • Scully C, Eisen D, Carrozzo M. Management of oral lichen planus. Am J Clin Dermatol 2000; 1: 287–306.
  • Partridge M. Head and neck cancer and precancer: can we use molecular genetics to make better predictions? Ann R Coll Surg Engl 1999; 81: 1–11.
  • Rapidis AD, Langdon JD, Patel MF, Harvey PW. STNMP. A new system for the clinico-pathological classification and identification of intra-oral carcinomata. Cancer 1977; 39: 204–9.
  • Shah JP. Cervical lymph node metastases: diagnostic, therapeutic and prognostic implications. Oncology 1990; 4: 61–9.
  • Woolgar JA, Scott J, Vaughan ED, Brown JS, West CR, Rogers S. Survival, metastasis and recurrence of oral cancer in relation to pathological features. Ann R Coll Surg Engl 1995; 77: 325–31.
  • Leemans CR, Tiwari R, Nauta JJP, van der Waal I, Snow GB. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 1993; 71: 452–6.
  • Kalnins IK, Leonard AG, Sako K, Razack MS, Shedd DP. Correlation between prognosis and degree of lymph node involvement in carcinoma of the oral cavity. Am J Surg 1977; 134: 450–4.
  • Alex JC, Sasaki CT, Krag DN, Wenig B, Pyle PB. Sentinel lymph node localisation in head and neck squamous cell carcinoma. Laryngoscope 2000; 110: 198–203.
  • Johnson JT, Myers E, Bedetti CD, Barnes EL, Schramm VL, Thearle PB. Cervical lymph node metastases: incidence and implications of extracapsular carcinoma. Arch Otolaryngol 1985; 111: 534–7.
  • Ferlito A, Shaha AR, Rinaldo A. The incidence of lymph node micrometastases in patients pathologically staged NO in cancer of the oral cavity and oropharynx. Oral Oncol 2002; 38: 3–5.
  • Ambrosch P, Brinck U. Detection of nodal micrometastases in head and neck cancer by serial sectioning and immunostaining. Oncology (Huntingt) 1996; 10: 1221–9.
  • McDonald LA, Walker DM, Gibbins JR. Cervical lymph node involvement in head and neck cancer detectable as expression of a spliced transcript of type II keratin K5. Oral Oncol 1998; 34: 276–83.
  • Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathological staging in squamous cell carcinoma of the head and neck. New Engl J Med 1995; 332: 429–35.
  • Brennan JA, Sidransky D. Molecular staging of head and neck squamous carcinoma. Cancer Metastasis Rev 1996; 15: 3–10.
  • Shah JP, Andersen PE. Evolving role of modifications in neck dissections for oral squamous carcinoma. Br J Maxillofac Surg 1995; 33: 3–8.
  • Fiend CR. The head and neck. In: Haagensenand CD, Feindand CR, Herterand FP, Slanetzand CA, Weinberg JA, editors. The Lymphatics in Cancer. Philadelphia, PA: W.B. Saunders, 1972; 59–227.
  • Loree TR, Strong E. Significance of positive margins in oral cavity squamous cell carcinoma. Am J Surg 1990; 160: 410–4.
  • Spiro RH, Huvos AG, Wong GY, Spiro JD, Gnecco CA, Strong EW. Predictive value of tumour thickness in squamous cell carcinoma confined to the tongue and floor of mouth. Am J Surg 1986; 152:345–51.
  • Morton RP, Ferguson CM, Lambie N, Whitlock RML. Tumour thickness in early tongue cancer. Arch Otolaryngol Head Neck Surg 1994; 120: 717–20.
  • Urist MM, O'Brien CJ, Soong Si, Visscher DW, Maddox WA. SCC of the buccal mucosa: analysis of prognostic factors. Am J Surg 1987; 154: 411–4.
  • Tytor M, Oloffson J. Prognostic factors in oral cavity carcinomas. Acta Otolaryngol (Stockholm) 1992; 492: 75–8.
  • Nason RW, Castillo NB, Sako K, Shedd DP. Cervical node metastases in early squamous cell carcinoma of the floor of the mouth: predictive value of multiple histopathologic parameters. World J Surg 1990; 14: 606–9.
  • Soo KC, Carter RL, O'Brien CJ, Barr LC, Bliss JM, Shaw Hi. Prognostic implications of perineural spread in squamous carcinomas of the head and neck. Laryngoscope 1986; 96: 1145–8.
  • Cawson RA, Binnie HW, Speight P, Barrett AW, Wright JM. In: Lucas's Pathology of Tumours of the Oral Tissue. 5th ed. London: Churchill Livingstone, 1998; 229–48.
  • Jacobson S, Shear M. Verrucous carcinoma of the mouth. J Oral Pathol 1972; 1: 66–75.
  • Ide F, Shimomaya T, Hone N, Kusama K. Basaloid squamous cell carcinoma of the oral mucosa: a new case and review of 45 cases in the literature. Oral Oncol 2002; 38: 120–4.
  • Ellis GL, Corio RL. Spindle cell carcinoma of the oral cavity: a clinico pathologic assessment of 59 cases. Oral Surg Oral Med Oral Pathol 1980; 50: 523–34.
  • Napier SS, Gormley JS, Newlands C, Ramsay-Baggs P. Adenosqua-mous carcinoma, a rare neoplasm with an aggressive course. Oral Surg Oral Med Oral Pathol 1995; 79: 607–11.
  • Jones AC, Freedmen PD, Kerpel SM. Oral adenoid squamous carcinoma: a report of three cases and review of the literature. J Oral Maxillofac Surg 1993; 51: 676–81.
  • Anneroth G, Hansen LS. A methodologic study of histologic classification and grading of malignancy in oral squamous cell carcinoma. Scand J Dent Res 1984; 92: 448–68.
  • Bryne M, Koppang HS, Lilleng R, Stene T, Bang G, Dabelsteen E. New malignancy grading is a better prognostic indicator than Broders' grading in oral squamous cell carcinomas. J Oral Pathol Med 1989; 18: 432–7.
  • Bryne M, Boysen M, Alfsen CG, et al. The invasive front of carcinomas. The most important area for tumour prognosis? Anti-cancer Res 1998; 18: 4757–64.
  • Odell EW, Jani P, Ahluwalia SM, Levison DA, Morgan PR. The prognostic value of individual histologic grading parameters in small lingual squamous cell carcinomas. Cancer 1994; 74: 789–94.
  • Piffko J, Bankfalvi A, Ofner D, et al. Prognostic value of histobiological factors (malignancy grading and AgNOR content) assessed at the invasive tumour front of oral squamous cell carcinomas. Br J Cancer 1997; 75: 1543–6.
  • Piffko J, Bankfalvi A, Ofner D, Rasch D, Joos U, Schmid KW. Standardised AgNOR analysis of the invasive tumour front in oral squamous cell carcinomas. J Pathol 1997; 182: 450–6.
  • Woolgar JA, Scott J. Prediction of cervical lymph node metastasis in squamous cell carcinomas of the tongue/floor of mouth. Head Neck 1995; 17: 463–72.
  • Helliwell TR, Woolgar JA. Minimum Dataset for Head and Neck Carcinoma. London: Royal College of Pathologists Publications, 2000.
  • Califano J, Westra WH, Meininger G, Corio R, Koch WH, Sidransky DGenetic progression and clonal relationship of recurrent premalig-nant head and neck lesions, Clin Cancer Res 2000; 6: 347–52.
  • Sankaranarayanan R, Mathew B, Jacob BJ, et al. Early findings from a community based cluster randomised, controlled oral cancer screening trial in Kerala, India. Cancer 2000; 88: 664–73.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.